Previous 10 | Next 10 |
Benitec Biopharma (BNTC) announces results of the interim analysis of the BB-301 Pilot Dosing Study for the treatment of Oculopharyngeal Muscular Dystrophy ((OPMD)), a chronic, life-threatening genetic disorder.Shares of the company up nearly 6% premarket.Patients with OPMD los...
Benitec Biopharma Announces Successful Results from the Interim Analysis of the BB-301 Pilot Dosing Study PR Newswire HAYWARD, Calif. , Feb. 24, 2021 /PRNewswire/ -- Highlights from the Interim Analysis: Biologically significant, hig...
Benitec Biopharma Announces 2020 Annual Stockholder Meeting HAYWARD, Calif. , Dec. 7, 2020 /PRNewswire/ -- Benitec Biopharma, Inc. (NASDAQ: BNTC), today announced that its 2020 Annual Meeting of Stockholders will be held virtually on Wednesday December 9, 2020 at 3...
Benitec Biopharma Announces Closing of $11.5 Million Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares PR Newswire HAYWARD, Calif., Oct. 6, 2020 HAYWARD, Calif. , Oct. 6, 2020 /PRNewswire/ -- Benitec Biopharma Inc. (...
MyoKardia (MYOK) +59% as Bristol to acquire the company for $225/Share.Kosmos Energy (KOS) +50% as company closed a Gulf of Mexico facility with Beal Bank USA and Trafigura Trading LLC.Enlivex Therapeutics (ENLV) +49%.Corvus Pharmaceuticals (CRVS) +38% on co-foun...
Gainers: American Renal Associates (ARA) +68%.IDT (IDT) +37%.Nano-X Imaging (NNOX) +36%.Westwater Resources (WWR) +24%.voxeljet (VJET) +21%.Houghton Mifflin Harcourt (HMHC) +21%.ProPhase Labs (PRPH) +19%.Lithium Americas (LAC) +19%.Telenav (TNAV) +18%.Assured Guaranty (AGO) +17...
Gainers: Aduro Biotech (ADRO) +442%, American Renal Associates (ARA) +69%, Nano-X Imaging (NNOX) +38%, CTI BioPharma (CTIC) +18%, ProPhase Labs (PRPH) +16%.Losers: Benitec Biopharma (BNTC) -36%, Mesoblast (MESO) -36%, Arcutis Biotherapeut...
Benitec Biopharma (BNTC) prices an underwritten public offering of ~3.23M shares of its common stock at a price of $3.10/share for an aggregate gross proceeds of ~$10M.Underwriters have an option to purchase up to 483.9k additional shares.Net proceeds from the offering will be ...
Benitec Biopharma Announces Pricing of $10.0 Million Public Offering PR Newswire HAYWARD, Calif., Oct. 2, 2020 HAYWARD, Calif. , Oct. 2, 2020 /PRNewswire/ -- Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "the Company"), a development-stage, gene the...
Mesoblast (MESO) -37% after FDA rejects cell therapy application for treatment-resistant graft-vs-host disease.Benitec Biopharma (BNTC) -26%.Greenpro Capital (GRNQ) -18%.Tuniu (TOUR) -14%.Hall of Fame Resort & Entertainment (HOFV) -13%.Iterum Therapeutics (ITRM) -12%.Oxbridge Re...
News, Short Squeeze, Breakout and More Instantly...
Benitec Biopharma Limited Company Name:
BNTC Stock Symbol:
NASDAQ Market:
Benitec Biopharma Limited Website:
2024-07-16 20:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-The post-dose average values for Total Pharyngeal Residue (i.e., the amount of solid food or liquid material remaining in the pharynx after the first swallow) remained meaningfully reduced at the 180-day post-dose assessment following the administration of the low dose of gene therapy BB-301 as ...
HAYWARD, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace ...